These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6209980)

  • 21. Modification of radiation and dihydroxyanthraquinone-induced cell lethality by cysteamine and N-ethylmaleimide.
    Kimler BF; Cheng CC
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1683-6. PubMed ID: 6480454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dihydroxyanthraquinone and radiation on G2 progression.
    Kimler BF
    Cancer Res; 1980 Jan; 40(1):42-6. PubMed ID: 7349902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.
    De Sanctis V; Alfò M; Di Rocco A; Ansuinelli M; Russo E; Osti MF; Valeriani M; Minniti G; Grapulin L; Musio D; Bracci S; Spagnoli A; Moleti ML; Tombolini V; Martelli M
    Hematol Oncol; 2017 Dec; 35(4):554-560. PubMed ID: 28078727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
    Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
    Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
    Molin J; Søgaard PE; Overgaard J
    Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour.
    von der Maase H
    Radiother Oncol; 1986 Sep; 7(1):47-68. PubMed ID: 2430317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
    Fox AM; Dosoretz AP; Mauch PM; Chen YH; Fisher DC; LaCasce AS; Freedman AS; Silver B; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):277-83. PubMed ID: 22019238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibrosing alveolitis after combined radio- and chemotherapy. A case report].
    Herrmann G; Hübner K
    Onkologie; 1988 Jun; 11(3):142-4. PubMed ID: 2457859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
    Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
    J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin-induced recall of radiation pneumonitis and epilation in lung and hair follicles of mouse.
    Vegesna V; Withers HR; McBride WH; Holly FE
    Int J Radiat Oncol Biol Phys; 1992; 23(5):977-81. PubMed ID: 1386355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
    Brusamolino E; Lunghi F; Orlandi E; Astori C; Passamonti F; Baraté C; Pagnucco G; Baio A; Franchini P; Lazzarino M; Bernasconi C
    Haematologica; 2000 Oct; 85(10):1032-9. PubMed ID: 11025593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG; Murray N; Warde P
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of single, fractionated and hyperfractionated irradiation on the development of normal tissue damage in rat lung.
    Giri PG; Kimler BF; Giri UP; Cox GG; Reddy EK
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):527-34. PubMed ID: 3972663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung damage in C57B1 mice following thoracic irradiation: enhancement by chemotherapy.
    Steel GG; Adams K; Peckham MJ
    Br J Radiol; 1979 Sep; 52(621):741-7. PubMed ID: 476389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique.
    Mornex F; Trillet V; Chauvin F; Ardiet JM; Schmitt T; Romestaing P; Carrie C; Mahe M; Mornex JF; Fournel P
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):23-30. PubMed ID: 2166018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.
    Morton RF; Jett JR; McGinnis WL; Earle JD; Therneau TM; Krook JE; Elliott TE; Mailliard JA; Nelimark RA; Maksymiuk AW
    Ann Intern Med; 1991 Nov; 115(9):681-6. PubMed ID: 1656827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.
    Kano M; Matsushita K; Rahmutulla B; Yamada S; Shimada H; Kubo S; Hiwasa T; Matsubara H; Nomura F
    Gene Ther; 2016 Jan; 23(1):50-6. PubMed ID: 26241176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cardiac sequelae after treatment of malignant tumors with radiotherapy or cytostatics in childhood.
    Mäkinen L; Mäkipernaa A; Rautonen J; Heino M; Pyrhönen S; Laitinen LA; Siimes MA
    Cancer; 1990 May; 65(9):1913-7. PubMed ID: 2372762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.